Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Article | IMSEAR | ID: sea-216003

ABSTRACT

Hypoglycemia in a child with acute lymphoblastic leukemia (ALL) often makes the clinician think of sepsis or metabolic disturbances due to relative adrenal insufficiency with steroid withdrawal. We report a rare scenario of drug-induced hypoglycemia in a child on treatment for ALL. Recurrent symptomatic episodes of hypoglycemia in a 4-year-girl on treatment for high-risk ALL were analyzed and it was surprising to note that the episodes were noted on early hours on Monday and Sunday nights. Detailed evaluation for the etiology and the workup was not contributory. With the background of drug history for ALL maintenance and occurrence of episodes on Mondays, possibility of drug-induced hypoglycemia secondary to cotrimoxazole was considered. Dose alteration for trimethoprim-sulfamethoxazole was considered stopping the drug is not feasible. Malnutrition was attributed as the coexisting risk factor in our child

2.
International Journal of Pediatrics ; (6): 185-188, 2014.
Article in Chinese | WPRIM | ID: wpr-444634

ABSTRACT

Objective To analysis the clinical characteristics and the long-term effect of children with acute lymphoblastic leukemia (ALL).Methods From 2005 to 2010,80 newly diagnosed ALL children were enrolled and treated with protocol based on ALL-BFM2002.The five-years overall survival (OS)and event-free survival(EFS) were analyzed by the method of Kaplan-Meier.Results For the 80 patients,male to female ratio is 1.22∶1.The median age was 4.3 years.33 were in standard risk(41.2%),37 were in medium risk(46.3%),and 10 were in high risk(12.5%).22 had white blood cell count ≥20 x 109/L(27.5%).three patients with BCR-ABL translocation(3.8%),one patient with MLL gene rearrangement(1.3%),17 patients with TEL-AML translocation (21.3%).During induction therapy,79 patients (98.8 %) achieved complete remission(CR).The five-years OS and EFS were (85.9 ± 4.0) % and (79.2 ± 4.7) % respectively.The five-years EFS:SR group (86.6 ± 6.4) %,IR group (81.1 ± 6.4) %,HR group (48.0 ± 16.4) %.The difference among risk groups was statistically significant(x2 =7.03,P <0.05).12 patients relapsed(15.0%),the median time from diagnosis to relapse was 23.5 months.11 patients died (13.8 %).Conclusion According to stratification by risk factors and risk-adapted therapy,the quality of ALL children's life had improved.

SELECTION OF CITATIONS
SEARCH DETAIL